Super-enhancer hypermutation alters oncogene expression in B cell lymphoma
Élodie Bal(Délégation Paris 5), Riccardo Dalla‐Favera(Columbia University), Laura Pasqualucci(Columbia University Irving Medical Center), Hossein Khiabanian(Rutgers, The State University of New Jersey), Antony B. Holmes(Cancer Genetics (United States)), Mohammad Hadigol(Rutgers, The State University of New Jersey), Sofija Vlasevska(Cancer Genetics (United States)), Jui Wan Loh(Southwestern Medical Center), Katia Basso(Cancer Genetics (United States)), Rahul Kumar(Indian Institute of Technology Hyderabad), Clarissa Corinaldesi(Cancer Genetics (United States)), Rajesh K. Soni(Columbia University), Ryan D. Morin(Simon Fraser University), Jasper Wong, Kostiantyn Dreval(Simon Fraser University), Laura K. Hilton(BC Cancer Agency)
Cited by 154
Related Papers
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
|Cancer Cell|2020|1.1k
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
|Nature Immunology|2006|771
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
|Blood|2013|396
Low energy availability, not exercise stress, suppresses the diurnal rhythm of leptin in healthy young women
|American Journal of Physiology-Endocrinology and Metabolism|2000|211